A Study of JNJ-79032421 Targeting Mesothelin for Advanced Stage Solid Tumors

Clinical trial NCT06255665 · COMPLETED

Trial details

NCT number: NCT06255665
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Stage Solid Tumors

Start date: 2024-02-09
Primary completion: 2025-06-23
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.